Cargando…
Kinome profiling of cholangiocarcinoma organoids reveals potential druggable targets that hold promise for treatment stratification
BACKGROUND: Cholangiocarcinoma is a rare but lethal cancer of the biliary tract. Its first-line treatment is currently restricted to chemotherapy, which provides limited clinical benefit. Kinase inhibitors targeting oncogenic intracellular signaling have changed the treatment paradigm of cancer over...
Autores principales: | Lieshout, Ruby, Faria, Alessandra V. S., Peppelenbosch, Maikel P., van der Laan, Luc J. W., Verstegen, Monique M. A., Fuhler, Gwenny M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9238224/ https://www.ncbi.nlm.nih.gov/pubmed/35764936 http://dx.doi.org/10.1186/s10020-022-00498-1 |
Ejemplares similares
-
Drug Discovery in Liver Disease Using Kinome Profiling
por: Yu, Bingting, et al.
Publicado: (2021) -
Kinome Profiling
por: Peppelenbosch, Maikel P.
Publicado: (2012) -
Label-Free Imaging Analysis of Patient-Derived Cholangiocarcinoma Organoids after Sorafenib Treatment
por: Koch, Michael, et al.
Publicado: (2022) -
Emerging organoid-immune co-culture models for cancer research: from oncoimmunology to personalized immunotherapies
por: Magré, Luc, et al.
Publicado: (2023) -
Improved intra-array and interarray normalization of peptide microarray phosphorylation for phosphorylome and kinome profiling by rational selection of relevant spots
por: Scholma, Jetse, et al.
Publicado: (2016)